FDA inspection
Yale University Institutional Review Board: FDA inspection ending Jun 26, 2025
FDA inspection 1276286 · New Haven, CT
Key facts
| Inspection ID | 1276286 |
|---|---|
| Firm | Yale University Institutional Review Board |
| FEI number | 1283697 |
| Address | 25 Science Park, 150 Munson St |
| City | New Haven |
| State | CT |
| ZIP | 06510-3208 |
| Fiscal year | 2025 |
| Inspection end date | Jun 26, 2025 |
| Project area | Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices |
| Product type | Biologics, Devices, Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data